QIAGEN EPS - Earnings per Share 2010-2023 | QGEN
QIAGEN annual and quarterly earnings per share history from 2010 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- QIAGEN EPS for the quarter ending March 31, 2023 was $0.37, a 44.78% decline year-over-year.
- QIAGEN EPS for the twelve months ending March 31, 2023 was $1.54, a 33.62% decline year-over-year.
- QIAGEN 2022 annual EPS was $1.84, a 16.74% decline from 2021.
- QIAGEN 2021 annual EPS was $2.21, a 44.44% increase from 2020.
- QIAGEN 2020 annual EPS was $1.53, a 950% decline from 2019.
| QIAGEN Annual EPS |
| 2022 |
$1.84 |
| 2021 |
$2.21 |
| 2020 |
$1.53 |
| 2019 |
$-0.18 |
| 2018 |
$0.82 |
| 2017 |
$0.17 |
| 2016 |
$0.34 |
| 2015 |
$0.55 |
| 2014 |
$0.48 |
| 2013 |
$0.30 |
| 2012 |
$0.56 |
| 2011 |
$0.42 |
| 2010 |
$0.62 |
| 2009 |
$0.67 |
| QIAGEN Quarterly EPS |
| 2023-03-31 |
$0.37 |
| 2022-12-31 |
$0.39 |
| 2022-09-30 |
$0.36 |
| 2022-06-30 |
$0.42 |
| 2022-03-31 |
$0.67 |
| 2021-12-31 |
$0.56 |
| 2021-09-30 |
$0.57 |
| 2021-06-30 |
$0.52 |
| 2021-03-31 |
$0.56 |
| 2020-12-31 |
$0.91 |
| 2020-09-30 |
$0.07 |
| 2020-06-30 |
$0.38 |
| 2020-03-31 |
$0.17 |
| 2019-12-31 |
$0.21 |
| 2019-09-30 |
$-0.71 |
| 2019-06-30 |
$0.19 |
| 2019-03-31 |
$0.13 |
| 2018-12-31 |
$0.26 |
| 2018-09-30 |
$0.26 |
| 2018-06-30 |
$0.16 |
| 2018-03-31 |
$0.14 |
| 2017-12-31 |
$-0.18 |
| 2017-09-30 |
$0.21 |
| 2017-06-30 |
$0.06 |
| 2017-03-31 |
$0.08 |
| 2016-12-31 |
$0.03 |
| 2016-09-30 |
$0.15 |
| 2016-06-30 |
$0.09 |
| 2016-03-31 |
$0.07 |
| 2015-12-31 |
$0.21 |
| 2015-09-30 |
$0.15 |
| 2015-06-30 |
$0.11 |
| 2015-03-31 |
$0.08 |
| 2014-12-31 |
$0.09 |
| 2014-09-30 |
$0.15 |
| 2014-06-30 |
$0.15 |
| 2014-03-31 |
$0.10 |
| 2013-12-31 |
$0.27 |
| 2013-09-30 |
$0.18 |
| 2013-06-30 |
$-0.23 |
| 2013-03-31 |
$0.08 |
| 2012-12-31 |
$0.17 |
| 2012-09-30 |
$0.13 |
| 2012-06-30 |
$0.15 |
| 2012-03-31 |
$0.13 |
| 2011-12-31 |
$-0.01 |
| 2011-09-30 |
$0.16 |
| 2011-06-30 |
$0.15 |
| 2011-03-31 |
$0.13 |
| 2010-12-31 |
$0.16 |
| 2010-09-30 |
$0.16 |
| 2010-06-30 |
$0.17 |
| 2010-03-31 |
$0.15 |
| 2009-12-31 |
$0.19 |
| 2009-09-30 |
$0.19 |
| 2009-06-30 |
$0.16 |
| 2009-03-31 |
$0.13 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.584B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
